×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CATX – perspective therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CATX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/27
07:00 am
catx
Perspective Therapeutics to Participate in Upcoming Investor Conferences in December
High
Report
Perspective Therapeutics to Participate in Upcoming Investor Conferences in December
11/25
11:07 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $16.00. They now have an "outperform" rating on the stock.
Medium
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $16.00. They now have an "outperform" rating on the stock.
11/25
08:02 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock, down previously from $24.00.
Medium
Report
Perspective Therapeutics, Inc. (NYSE: CATX) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock, down previously from $24.00.
11/22
09:41 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $22.00 to $16.00. They now have an "outperform" rating on the stock.
High
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $22.00 to $16.00. They now have an "outperform" rating on the stock.
11/21
06:39 pm
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock, down previously from $20.00.
High
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock, down previously from $20.00.
11/21
07:15 am
catx
Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
High
Report
Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
11/15
04:08 pm
catx
Perspective Therapeutics to Discuss Data on [212Pb]VMT-a-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
High
Report
Perspective Therapeutics to Discuss Data on [212Pb]VMT-a-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
11/12
04:05 pm
catx
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
Medium
Report
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:05 pm
catx
perspective therapeutics, inc.
IN-LINE
Report
-7.0%
perspective therapeutics, inc.
8/12/2024
04:05 pm
catx
perspective therapeutics, inc.
BEAT
Report
5.7%
perspective therapeutics, inc.
8/12/2024
04:05 pm
catx
perspective therapeutics, inc.
BEAT
Report
5.7%
perspective therapeutics, inc.
8/12/2024
04:05 pm
catx
perspective therapeutics, inc.
BEAT
Report
15.7%
perspective therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/6
04:05 pm
catx
Form 4 Perspective Therapeutics For: Dec 04 Filed by: HENSON HEIDI
Low
Report
Form 4 Perspective Therapeutics For: Dec 04 Filed by: HENSON HEIDI
12/4
05:23 pm
catx
Form 4 Perspective Therapeutics For: Dec 04 Filed by: Spoor Johan M.
Low
Report
Form 4 Perspective Therapeutics For: Dec 04 Filed by: Spoor Johan M.
12/4
05:17 pm
catx
Form 4/A Perspective Therapeutics For: Nov 25 Filed by: Williamson Robert F III
Low
Report
Form 4/A Perspective Therapeutics For: Nov 25 Filed by: Williamson Robert F III
12/4
05:15 pm
catx
Form 4/A Perspective Therapeutics For: Nov 25 Filed by: Spoor Johan M.
Low
Report
Form 4/A Perspective Therapeutics For: Nov 25 Filed by: Spoor Johan M.
12/4
06:03 am
catx
Form 8-K Perspective Therapeutics For: Dec 03
Medium
Report
Form 8-K Perspective Therapeutics For: Dec 03
11/27
07:05 am
catx
Form 4 Perspective Therapeutics For: Nov 25 Filed by: Williamson Robert F III
High
Report
Form 4 Perspective Therapeutics For: Nov 25 Filed by: Williamson Robert F III
11/27
07:00 am
catx
Form 4 Perspective Therapeutics For: Nov 25 Filed by: Hunt Jonathan Robert
High
Report
Form 4 Perspective Therapeutics For: Nov 25 Filed by: Hunt Jonathan Robert
11/26
07:00 am
catx
Form 4 Perspective Therapeutics For: Nov 25 Filed by: Spoor Johan M.
High
Report
Form 4 Perspective Therapeutics For: Nov 25 Filed by: Spoor Johan M.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: